Your current location:HOME >health >Chinese scientist awarded for groundbreaking work in transplantation, cellular therapy 正文
TIME:2024-05-21 10:37:19 Source: Internet compilationEdit:health
"I want to say this award is not only a great honor for me, but also an affirmation of my team, and
"I want to say this award is not only a great honor for me, but also an affirmation of my team, and even more an incentive for the rapid development of hematopoietic stem cell transplantation in China," says Huang Xiaojun.
SAN ANTONIO, the United States, Feb. 25 (Xinhua) -- Chinese scientist Huang Xiaojun won a top international award here on Friday for his groundbreaking work known as Beijing Protocol in the transplantation and cellular therapy.
The esteemed professor, an Academician of the Chinese Academy of Engineering and Director of the Institute of Hematology at Peking University, received the prestigious annual Center for International Blood and Marrow Transplant Research (CIBMTR) Distinguished Service Award during the 2024 Tandem Meetings.
This event serves as a platform for leading global experts to collaboratively share crucial insights dedicated to enhancing and preserving the lives of individuals grappling with blood-related disorders.
"I am deeply honored," said Huang in his remarks. "I want to say this award is not only a great honor for me, but also an affirmation of my team, and even more an incentive for the rapid development of hematopoietic stem cell transplantation in China."
Huang established a series of key techniques of non-T cell depleted haploidentical transplantation, which gradually developed to the novel G-CSF/ATG based Beijing Protocol, increasing the 3-year survival rate from approximately 20 percent to about 70 percent in haploidentical transplantation treating leukemia, Michael Verneris, chair of the Advisory Committee of the CIBMTR, told the fully-packed meeting.
Huang Xiaojun speaks with a patient at Peking University People's Hospital in Beijing, capital of China, July 6, 2023. TO GO WITH "Chinese scientist awarded for groundbreaking work in transplantation, cellular therapy" (Xinhua/Zhang Yuwei)
Verneris reported that the Beijing Protocol techniques have been adopted in over 190 centers in China, resulting in a significant increase in haploidentical transplantation from almost zero to 65 percent by 2022. The protocol has also been extended to countries such as South Korea, Italy and France.
"Currently, it (the Beijing Protocol) is the most widely used haplo-HSCT system with the best curative effect around the world," the CIBMTR expert said, adding that Huang has also made remarkable contributions to promoting global cooperation in this field.
"This award will encourage me to make greater contributions to promote the development of hematology in China, and also promote the cooperation between China and the world in the future," Huang said.
The CIBMTR, initially set up in 1972, collaborates with the global scientific community to advance hematopoietic cell transplantation (HCT) and cellular therapy worldwide to increase survival and enrich the quality of life for patients, according to its website.
The 2024 Tandem Meetings on Feb. 21-24, co-organized by the American Society for Transplantation and Cellular Therapy and the CIBMTR, have attracted several thousand doctors, researchers and healthcare professionals from all over the world.
(Editor:Wang Su)
Insider Q&A: CIA's chief technologist's cautious embrace of generative AI2024-05-21 10:36
Baidu strongly denies rumor of link between its AI tool and China’s military research2024-05-21 10:16
AI tech helps in early detection of pancreatic cancer2024-05-21 09:41
Advanced technologies spur low2024-05-21 09:06
Uber and Lyft say they'll stay in Minnesota after Legislature passes driver pay compromise2024-05-21 08:52
Chinese tech firms strive for leadership in global e2024-05-21 08:47
New plant species discovered in SW China2024-05-21 08:34
Day 4 of the Masters at a glance2024-05-21 07:59
Trump accepts a VP debate but wants it on Fox News. Harris has already said yes to CBS2024-05-21 07:52
2023 Beijing Culture Forum to be held2024-05-21 07:52
Cruise worker 'murders newborn son on board ship': Shocked co2024-05-21 10:19
It's almost April 15. Here's how to reduce stress and get your taxes done2024-05-21 10:14
Excessive nitrogen fertilizer yields less attractive apples: research2024-05-21 10:09
Int'l scientists conduct joint experiments with China's artificial sun team2024-05-21 10:09
Kevin Pillar gets 1,000th career hit in Angels' win at Texas2024-05-21 09:39
Going bald gracefully! A2024-05-21 08:26
Scientists develop new artificial leaf2024-05-21 08:16
China releases first pan2024-05-21 08:11
I was 'brokefished' by my friend for £4002024-05-21 08:08
China yields remarkable outcomes of sci2024-05-21 08:00